CARsgen Therapeutics Holdings Limited (HKG:2171)
Hong Kong · Delayed Price · Currency is HKD 12.60
+0.15 (1.20%)
Sep 30, 2026, 4:08 PM HKT
HKG:2171 Market Cap
HKG:2171 has a market cap or net worth of 7 billion as of September 30, 2026. Its market cap has decreased by -34.41% in one year.
Market Cap
7.00B
Enterprise Value
5.46B
Revenue
157.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.60
ChartMarket Cap Chart
Since June 18, 2021, HKG:2171's market cap has decreased from 17.02B to 7.00B, a decrease of -58.87%. That is a compound annual growth rate of -15.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 7.00B | -15.19% |
| Dec 31, 2025 | 8.25B | 63.11% |
| Dec 31, 2024 | 5.06B | 35.24% |
| Dec 29, 2023 | 3.74B | -56.36% |
| Dec 30, 2022 | 8.57B | -45.06% |
| Dec 31, 2021 | 15.61B | -8.30% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 9.03B |
| Suzhou Ribo Life Science | 8.72B |
| CStone Pharmaceuticals | 8.19B |
| Alphamab Oncology | 7.75B |
| LongBio Pharma (Suzhou) | 7.62B |
| Shanghai Haohai Biological Technology | 7.16B |
| Lepu Biopharma | 6.87B |
| Shaanxi Micot Pharmaceutical Technology | 6.60B |